A trade organisation representing pharma manufacturers in Europe has said plans to restrict the use of fluorinated substances known as PFAS could make manufacturing “grind
With all the excitement in recent years about the potential for digital health technologies to relieve pressures on health systems and improve patient outcomes, there has
AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib
Pollution by the pharmaceutical, healthcare, and agricultural sectors is driving the development of 'superbug' strains of bacteria that have become resistant to every know
A consortium of industry and academic groups – led by Johnson & Johnson's pharma division Janssen – has been set up to tackle the environmental impact of
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceut